Related Experiment Video
Updated: Nov 8, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
LncRNA NONMMUT055714 acts as the sponge of microRNA-7684-5p to protect against postoperative cognitive dysfunction
Changwei Wei1, Yi Sun1, Jing Wang1
1Department of Anesthesiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Abstract:
Postoperative cognitive dysfunction (POCD) is a neurological complication of surgery especially common in elderly patients. In this study, we investigated the role of NONMMUT055714 in POCD via regulation of miR-7684-5p. In a POCD mouse model, we induced overexpression of NONMUTT055714 via transfection of lentivrus into the hippocampus, and used the Morris water maze for assessment of cognitive function. Silencing of NONMUTT055714 and miR-7684-5p was induced in primary hippocampal neurons to observe the effects of these regulatory RNAs on cellular processes. Bioinformatics analysis and a double luciferase reporter experiment were performed to further explore the relationship between NONMMUT055714, miR-7684-5p, and SORLA. Cell and animal rescue experiments were performed to verify the ability of miR-7684-5p to reverse the protective effects of NONMMUT055714 overexpression in POCD. We observed that NONMMUT055714 has decreased expression in the POCD mouse model. Overexpression of NONMMUT055714 protected against cognitive impairment of the POCD mouse model in vivo. We identified miR-7684-5p as a NONMMUT055714-related miRNA and in turn as an upstream regulator of SORLA. We found that NONMMUT055714 downregulation is associated with decreased SORLA, increased Aβ and p-tau expression, increased inflammatory biomarkers, increased markers of oxidative stress, and increased neuronal apoptosis in vitro. The effects of NONMMUT055714 downregulation were reversed by silencing miR-7684-5p in vitro and in vivo. Taken together, our findings suggest that NONMMUT055714 is protective against the development of POCD via its function as a ceRNA (or miRNA sponge) in the regulation of miR-7684-5p and SORLA. We therefore propose NONMMUT055714 as a novel target for the investigation and prevention of POCD.
Insights
NONMMUT055714 protects against postoperative cognitive dysfunction (POCD) by regulating miR-7684-5p and SORLA. This study identifies NONMMUT055714 as a potential therapeutic target for preventing POCD.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Postoperative cognitive dysfunction (POCD) is a common neurological complication in elderly patients after surgery.
- The underlying molecular mechanisms of POCD remain incompletely understood, highlighting the need for further research.
Purpose of the Study:
- To investigate the role of NONMMUT055714 in the development of POCD.
- To elucidate the regulatory pathway involving NONMMUT055714, miR-7684-5p, and SORLA in POCD.
Main Methods:
- Utilized a POCD mouse model with hippocampal NONMMUT055714 overexpression and silencing experiments in primary neurons.
- Employed Morris water maze for cognitive assessment, bioinformatics, and dual-luciferase reporter assays.
- Conducted cell and animal rescue experiments to validate regulatory interactions.
Main Results:
- NONMMUT055714 expression was decreased in the POCD model; its overexpression ameliorated cognitive impairment.
- NONMMUT055714 acts as a competing endogenous RNA (ceRNA) for miR-7684-5p, regulating SORLA.
- Downregulation of NONMMUT055714 correlated with increased Aβ, p-tau, inflammation, oxidative stress, and neuronal apoptosis, effects reversed by miR-7684-5p silencing.
Conclusions:
- NONMMUT055714 exerts a protective effect against POCD by sponging miR-7684-5p and modulating SORLA expression.
- NONMMUT055714 represents a promising novel therapeutic target for the prevention and treatment of POCD.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
